You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoproliferative Disorders

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)

Not yet recruiting
  • Lymphoproliferative Disorders
  • +3 more
  • No intervention
  • (no location specified)
Jan 30, 2023

Liquid Biopsy to Enable Diagnostics and Monitoring for

Recruiting
  • Lymphoproliferative Disorders
  • Lymphoproliferative Disorder Following Transplantation
  • Liquid biopsy
  • Basel, Switzerland
  • +5 more
Mar 24, 2023

Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)

Recruiting
  • Epstein-Barr Virus Infections
  • +3 more
  • Nivolumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

T-Cell Tumor, Lymphoproliferative Disorders Trial in Ann Arbor (Pacritinib)

Not yet recruiting
  • T-Cell Neoplasm
  • Lymphoproliferative Disorders
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Oct 6, 2022

Recurrent Lymphoproliferative Disorder, Refractory Lymphoproliferative Disorder Trial in Duarte (Leflunomide)

Active, not recruiting
  • Recurrent Lymphoproliferative Disorder
  • Refractory Lymphoproliferative Disorder
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Post-transplant Lymphoproliferative Disorder Trial in Saint Louis (Polatuzumab vedotin, Rituximab, CHP)

Not yet recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Polatuzumab vedotin
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 9, 2023

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Recruiting
  • Benign Lymphoproliferative Disorder
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Metastatic Cancer, Solid Tumor Cancer, Lymphoproliferative Disorders Trial in Boulder (Written Exposure Therapy)

    Recruiting
    • Metastatic Cancer
    • +5 more
    • Written Exposure Therapy
    • Boulder, Colorado
      University of Colorado Boulder
    Sep 13, 2023

    Pathogenesis of Hematologic Malignancies

    Enrolling by invitation
    • Acute Leukemia
    • +3 more
    • blood draw, bone marrow procedure, or tissue biopsy
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Sep 9, 2022

    Severe COVID-19 Infection in CLL or B-NHL Who Received

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
      • (no location specified)
      Apr 6, 2023

      Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

      Recruiting
      • Lymphoproliferative Disorders
      • +4 more
      • Immunosuppression Only Conditioning
      • +3 more
      • Bethesda, Maryland
      • +1 more
      Jan 25, 2023

      Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

      Active, not recruiting
      • Post-transplant Lymphoproliferative Disorder
      • Cleveland, Ohio
        Cleveland Clinic, Case Comprehensive Cancer Center
      Jan 16, 2023

      Lymphoma Trial in Stanford (rituximab)

      Completed
      • Lymphoma
      • rituximab
      • Stanford, California
        Stanford University Medical Center
      May 25, 2022

      Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

      Recruiting
      • Lymphoproliferative Disorders
      • +4 more
      • Busulfan test dose
      • +8 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Breast Cancer, Stage 0, Colorectal Cancer Stage I, Head Neck Cancer Stage I Trial (CaRE@Home intervention)

      Not yet recruiting
      • Breast Cancer, Stage 0
      • +11 more
      • CaRE@Home intervention
      • (no location specified)
      Jun 9, 2023

      Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

      Not yet recruiting
      • Immune System Diseases
      • +15 more
      • observational cohort study
      • (no location specified)
      Jul 23, 2023

      Myeloproliferative Disorders, Lymphoproliferative Disorders Trial in Pierre-Bénite (Blood collection for the evaluation of the

      Not yet recruiting
      • Myeloproliferative Disorders
      • Lymphoproliferative Disorders
      • Blood collection for the evaluation of the anti-drugs sensitivity
      • Pierre-Bénite, France
      • +1 more
      Mar 2, 2022

      Follicular Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Seattle (Laboratory Biomarker

      Active, not recruiting
      Has Results
      • Follicular Lymphoma
      • +2 more
      • Laboratory Biomarker Analysis
      • Pembrolizumab
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Dec 6, 2022

      Accuracy Evaluation of the IdentiClone Dx IGH Assay

      Not yet recruiting
      • B-Cell Lymphoproliferative Disorder
      • IdentiClone Dx IGH (IC IGH Dx) Assay
      • San Diego, California
      • +2 more
      Oct 30, 2023

      Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and

      Recruiting
      • Lymphomatoid Granulomatosis
      • +3 more
      • Interferon
      • Rituxan and EPOCH
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,

      Recruiting
      • Primary T-cell Immunodeficiency Disorders
      • +4 more
      • Immunosuppression Only Conditioning -Closed with amendment L
      • +4 more
      • Bethesda, Maryland
      • +1 more
      Jul 26, 2022

      Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)

      Recruiting
      • Lymphoma
      • +7 more
      • ATLCAR.CD30 cells
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Dec 2, 2022

      Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland

      Not yet recruiting
      • Allogeneic Stem Cell Transplant Candidate
      • +4 more
      • Cellular therapy product
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      Jul 1, 2022

      Epstein-Barr Virus Infection moniToring in renAl Transplant

      Recruiting
      • EBV Infection
      • +3 more
      • EBV DNA in whole blood and plasma
      • Aarhus, Central Region Denmark, Denmark
      • +2 more
      Dec 12, 2022

      Childhood Acute Lymphoblastic Leukemia/Lymphoma

      Recruiting
      • Childhood Leukemia and Lymphoma
        • Petah Tikva, Israel
        • +1 more
        Sep 30, 2021